Clinical Trials Logo

Clinical Trial Summary

The primary goal of the study is to assess the residual effects of heavy drinking on academic performance. The investigators will also explore whether these effects differ by family history of alcohol abuse and hangover symptoms, as well as compare males and females with respect to these effects. The primary hypothesis is that intoxication (0.10 g% blood alcohol concentration [BAC]) with an alcoholic beverage impairs next-day academic performance, as measured by scores on quizzes, standardized academic achievement tests, and standardized neurobehavioral assessments. The secondary hypothesis is that family-history-positive individuals will show a greater performance decrement the day after heavy drinking than family-history-negative individuals.


Clinical Trial Description

The primary goal of the study is to assess the effect of heavy drinking on next day academic performance. A placebo-controlled 2-period crossover design will be used to compare the effects of dosing status on academic performance, with participants serving as their own controls. Participants are dosed on two separate occasions, once with non-alcoholic beverage and the other time with alcoholic beverage sufficient to raise blood alcohol to 0.10 g%. The morning after dosing, participants' academic performance is measured using a standardized achievement test (Graduate Record Exam). Participants' cognition is tested using the the Psychomotor Vigilance Test (PVT). Data on participants' demographics, family history of drinking problems and alcohol use. We are also collecting information on hangover symptoms and sleep quality the morning after dosing, in addition to participants' self ratings of academic performance. The procedure is conducted twice with one week in between, switching the individuals' dosing status, presenting a different, but comparable lecture and reading, and administering a different quiz based on the new lecture and reading and a different, but comparable standardized achievement exam. This design is intended to test the hypothesis that intoxication (0.10 g% BAC) with alcoholic beverage impairs next-day academic performance. Participation involves a total of five sessions over a two week period. Participants are undergraduates who volunteer and meet inclusion criteria. Prior to enrollment, volunteers are screened to ensure they meet initial eligibility criteria. Eligible volunteers receive written instructions regarding participation and are scheduled for the study sessions. Participants report to the study site on the first session for an additional screening by the study physician and go through the informed consent process. Eligible participants report back the next week for their first dosing night where they receive several drinks (alcohol or placebo) sufficient to raise their Breath Alcohol Level (BrAC) to 0.10 g%; the amount of beverage administered is based on their body weight. Those receiving placebo receive the same total quantity of beverage as those receiving alcohol. Both alcohol-dosed and placebo-dosed participants are breath-tested after they have completed their required dose. Participants sleep at the study site and are monitored overnight. The next morning they are awakened and are escorted to the exam room for the performance trials. They return the next week for the second dosing night/dosing morning, and receive either alcohol or placebo, depending on what was administered the previous week, and take different but comparable performance tests. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00183170
Study type Interventional
Source Boston University
Contact
Status Completed
Phase Phase 2
Start date February 2004
Completion date January 2009

See also
  Status Clinical Trial Phase
Recruiting NCT03222375 - SQUEDâ„¢ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism N/A
Completed NCT00247585 - Hangover, Congeners, Sleep and Occupational Performance Phase 2
Completed NCT02557425 - Prophylaxis Against Malaria to Enhance Child Development (PROTECT Study)
Completed NCT00515294 - Acute and Residual Effects of Caffeinated Beer Phase 2
Completed NCT03268590 - Neuroimaging During Pure Oxygen Breathing Phase 4
Recruiting NCT03862950 - A Trial of Metformin in Individuals With Fragile X Syndrome (Met) Phase 2
Completed NCT03407729 - Measuring Brain Activity of School Age Children
Active, not recruiting NCT04937452 - Dopaminergic Therapy for Frontotemporal Dementia Patients Phase 2
Terminated NCT01506349 - Assessing Neurocognitive Effects of Gluten Exposure N/A
Enrolling by invitation NCT05934422 - NiPPeR Randomised Trial - Child Follow Up Study N/A
Completed NCT01782378 - Scalp Application of LED Therapy to Improve Thinking and Memory in Veterans With Gulf War Illness N/A
Completed NCT01953068 - Executive Reaction Time Test in Assessment of Cognitive Dysfunction After Aortic Valve Procedures
Completed NCT01061242 - Intensive Care Unit (ICU) Sleep Quality and Neurocognitive Performance N/A
Recruiting NCT02306460 - Frontal Cognitive Control Functions Before and After Percutaneous Catheter Procedures in Treatment of Atrial Fibrillation
Completed NCT02680210 - Self-defining Memories in Patients With a TBI N/A
Completed NCT00586638 - Training Cognitive Control Processes in Older Adults N/A
Recruiting NCT05657860 - Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome Phase 4
Recruiting NCT04289142 - Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients Phase 4
Completed NCT01150071 - Growth, Health and Development in Children Born Extremely Preterm N/A
Recruiting NCT05432349 - Rett Syndrome Registry